Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic introgression among charr species in the Shiretoko Peninsula, Japan.

Journal of fish biology·2026
Same author

Large-scale environmental DNA survey reveals niche axes of a regional coastal fish community.

Scientific reports·2026
Same author

Rechallenge of immune checkpoint inhibitor after local therapy for immune checkpoint inhibitor-resistant non-small cell lung cancer.

Chinese clinical oncology·2025
Same author

A link between evolution and society fostering the UN sustainable development goals.

Evolutionary applications·2024
Same author

Environmental DNA unveils deep phylogeographic structure of a freshwater fish.

Molecular ecology·2024
Same author

Understanding seasonal migration of Shishamo smelt in coastal regions using environmental DNA.

PloS one·2020

Related Experiment Video

Updated: Jun 28, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

[Contribution to survival rate improvement].

Kazuo Hatano1, Mitsuhiro Sakai, Hitoshi Araki

  • 1Division of Radiation Oncology, Chiba Cancer Center.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 18, 2008
PubMed
Summary

Altered fractionated radiotherapy, especially hyper-fractionated radiotherapy, significantly improves loco-regional control and survival for locally advanced head and neck squamous cell carcinoma (HNSCC). Further research is needed to optimize treatment selection.

Related Experiment Videos

Last Updated: Jun 28, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Area of Science:

  • Oncology
  • Radiation Oncology

Background:

  • Conventional radiotherapy outcomes are poor for locally advanced head and neck squamous cell carcinoma (HNSCC).
  • Altered fractionation techniques and chemoradiotherapy show promise for improving treatment efficacy.

Purpose of the Study:

  • To evaluate the efficacy of altered fractionated radiotherapy and concomitant chemoradiotherapy in locally advanced HNSCC.
  • To compare the survival benefits of hyper-fractionated radiotherapy versus accelerated radiotherapy.

Main Methods:

  • Meta-analysis and collective data review.
  • Comparison of survival outcomes between different radiotherapy fractionation schedules and chemoradiotherapy approaches.

Main Results:

  • Altered fractionated radiotherapy significantly improved loco-regional control.
  • Hyper-fractionated radiotherapy demonstrated a greater survival benefit (8% at 5 years) compared to accelerated radiotherapy (2-3.4% at 5 years).
  • Benefits were more pronounced for primary tumors, younger patients, and those with good performance status.

Conclusions:

  • Hyper-fractionated radiotherapy offers a significant survival advantage for locally advanced HNSCC.
  • Further investigation is required to determine optimal patient selection, chemoradiotherapy combinations, and dose schedules.
  • Comparing IMRT with altered fractionation requires evaluation.